Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.

Sellar RS, Rowntree C, Vora AJ, Furness CL, Goulden N, Mitchell C, Moorman AV, Hough R.

Br J Haematol. 2018 May;181(4):515-522. doi: 10.1111/bjh.15208. Epub 2018 Apr 24.

PMID:
29687881
2.

The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.

Furness CL, Mansur MB, Weston VJ, Ermini L, van Delft FW, Jenkinson S, Gale R, Harrison CJ, Pombo-de-Oliveira MS, Sanchez-Martin M, Ferrando AA, Kearns P, Titley I, Ford AM, Potter NE, Greaves M.

Leukemia. 2018 Sep;32(9):1984-1993. doi: 10.1038/s41375-018-0046-8. Epub 2018 Mar 20.

3.

Early morphological response is significantly associated with, but does not accurately predict, relapse in teenagers and young adults aged 10-24 years with acute lymphoblastic leukaemia (ALL): results from UKALL2003.

Furness CL, Kirkwood A, Rowntree C, Vora A, Mitchell C, Samarasinghe S, Goulden N, Moorman A, Hough R.

Br J Haematol. 2019 Feb;184(4):663-666. doi: 10.1111/bjh.15150. Epub 2018 Feb 22. No abstract available.

PMID:
29468646
4.

BSH Guideline: management of thrombotic and haemostatic issues in paediatric malignancy.

Sibson KR, Biss TT, Furness CL, Grainger JD, Hough RE, Macartney C, Payne JH, Chalmers EA; British Society for Haematology.

Br J Haematol. 2018 Feb;180(4):511-525. doi: 10.1111/bjh.15112. Epub 2018 Jan 31. No abstract available.

PMID:
29384193
5.

Post-allograft relapse of acute lymphoblastic leukemia: rational use of the new targeted therapies.

Furness CL, Marks DI.

Curr Med Res Opin. 2018 Mar;34(3):517-519. doi: 10.1080/03007995.2017.1412946. Epub 2018 Jan 19. No abstract available.

PMID:
29195485
6.

Cancer Patient Experience in the Teenage Young Adult Population- Key Issues and Trends Over Time: An Analysis of the United Kingdom National Cancer Patient Experience Surveys 2010-2014.

Furness CL, Smith L, Morris E, Brocklehurst C, Daly S, Hough RE.

J Adolesc Young Adult Oncol. 2017 Sep;6(3):450-458. doi: 10.1089/jayao.2016.0058. Epub 2017 May 19.

7.

Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.

Giebel S, Labopin M, Ibatici A, Browne P, Czerw T, Socie G, Unal A, Kyrcz-Krzemien S, Bacigalupo A, Goker H, Potter M, Furness CL, McQuaker G, Beelen D, Milpied N, Campos A, Craddock C, Nagler A, Mohty M.

Oncologist. 2016 Mar;21(3):377-83. doi: 10.1634/theoncologist.2015-0314. Epub 2016 Feb 11.

8.

Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.

Mansur MB, van Delft FW, Colman SM, Furness CL, Gibson J, Emerenciano M, Kempski H, Clappier E, Cave H, Soulier J, Pombo-de-Oliveira MS, Greaves M, Ford AM.

Br J Haematol. 2015 Nov;171(4):574-84. doi: 10.1111/bjh.13613. Epub 2015 Jul 24.

9.

Protracted dormancy of pre-leukemic stem cells.

Ford AM, Mansur MB, Furness CL, van Delft FW, Okamura J, Suzuki T, Kobayashi H, Kaneko Y, Greaves M.

Leukemia. 2015 Nov;29(11):2202-7. doi: 10.1038/leu.2015.132. Epub 2015 May 28.

10.

Hydroxycarbamide and erythropoietin in the preoperative management of children with sickle cell anaemia undergoing moderate risk surgery.

Furness CL, O'Driscoll S, Davenport M, Morrison G, Height SE, Dick MC, Rees DC.

Br J Haematol. 2009 Feb;144(3):453-4. doi: 10.1111/j.1365-2141.2008.07463.x. Epub 2008 Nov 17. No abstract available.

PMID:
19036093

Supplemental Content

Loading ...
Support Center